Thomas Von Essen, Regional Administrator of FEMA Region II, discusses support to New York City in late March.

Thomas Von Essen, Regional Administrator of FEMA Region II, discusses support to New York City in late March. Kathy Willens/AP

Coronavirus Roundup: FEMA Prepares for Hurricane Season During a Pandemic; Whistleblower Cases Spike

There's a lot to keep track of. Here’s today’s list of news updates and stories you may have missed.

During a town hall on Fox News on Sunday evening, President Trump said he is “very confident” there will be a coronavirus vaccine by the end of the year, despite warnings by experts that it is impossible to predict when, or even if, a vaccine eventually will be developed. Trump also said the U.S. death toll from COVID-19 could reach 90,000. Here are some other recent headlines from over the weekend and today you might have missed. 

According to the watchdog group Project on Government Oversight, 31 coronavirus-related whistleblower cases have been filed with the Office of Special Counsel and 15 whistleblowers have filed relation complaints. “Far more federal employees than previously known have blown the whistle with coronavirus-related concerns as the government has raced to initially contain and more recently mitigate the spread of the virus,” said POGO. “It is unknown how much overlap there is between the individuals filing these disclosures and those filing retaliation complaints.”

The National Institutes of Health said on Monday it is enrolling participants in a study to determine the rate of coronavirus infection in children and their families. The “study team will rapidly enroll 6,000 people from 2,000 U.S. families already participating in NIH-funded pediatric research studies in 11 cities,” said a press release. 

On Friday, the Food and Drug Administration issued emergency authorization for a possible coronavirus treatment. “Based on evaluation of the emergency use authorization criteria and the scientific evidence available, it was determined that it is reasonable to believe that remdesivir may be effective in treating COVID-19,” said the FDA. “Given there are no adequate, approved, or available alternative treatments, the known and potential benefits to treat this serious or life-threatening virus currently outweigh the known and potential risks.” 

The FDA is imposing stricter rules on coronavirus antibody tests following a House investigation. “Manufacturers of antibody tests must now apply for emergency use authorization within 10 business days after their products hit the market, under a policy announced Monday,” Politico reported.” If a test does not meet the FDA's specificity and sensitivity criteria, its manufacturer must suspend distribution.”

Reps. Bennie G. Thompson, D-Miss., and Rep. Peter DeFazio, D-Ore., called on Trump on Friday night to approve funding for the Federal Emergency Management Agency to pay for burial costs for coronavirus victims. They noted the agency has done so in previous disasters. 

On Monday, Sen. Bernie Sanders, I-Vt., and Rep. Ro Khanna, D-Calif., introduced a bill that would mobilize the federal government to increase production of medical equipment. “The Trump administration has failed to utilize the full powers of the federal government, including special authorities like the Defense Production Act to respond to the urgent needs of states and communities to save lives,” said the press release. Their legislation would provide $75 billion for the administration to manufacture or purchase ventilators, testing equipment, personal protective gear, approved vaccines and more. 

The White House is blocking Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and White House coronavirus task force member, from testifying before a House Appropriations subcommittee hearing on Wednesday. “While the Trump Administration continues its whole-of-government response to COVID-19, including safely opening up America again and expediting vaccine development, it is counterproductive to have the very individuals involved in those efforts appearing at congressional hearings,” said White House spokesman Judd Deere. “We are committed to working with Congress to offer testimony at the appropriate time,” The Washington Post reported on Friday evening. 

However, Fauci is expected to testify before the Republican-led Senate Health, Education Labor and Pensions Committee on May 12. “Chairman [Lamar] Alexander looks forward to hearing from Dr. Fauci and other administration officials at the Senate health committee’s second hearing back,” said a spokesperson for the Tennessee senator, ABC News reported

NASA, the European Space Agency and Japan Aerospace Exploration Agency are hosting a virtual hackathon at the end of the month to come up with coronavirus solutions using Earth’s observational data. Read more from NextGov’s full coverage

Even the Supreme Court is working from home during the pandemic. Starting today, justices will hear oral arguments remotely and for the first time the public can listen live. Read here how you can tune in. 

The General Services Administration has been using its time in telework to recruit more technology staff and reduce its office space, Federal News Networked reported. “The government has really shifted on a dime in how we’re interacting with each other,” said Dominic Sale, assistant commissioner of solutions at GSA’s Technology Transformation Services. “If anyone knows anything about [the] government, it does sometimes take a crisis to make us move quickly, and then it’s really hard to change after that.” 

Axios profiled how FEMA is getting ready for a “coronavirus infected” hurricane season, which starts on June 1. “The agency has taken over vacant office space in downtown Washington, D.C., and set up an additional command center—called a “surge” National Response Coordination Center—for staff across the government to handle the non-COVID catastrophes threatening America this summer,” Axios reported.

“We're doing a lot of things that are not necessarily in any playbook that has existed,” FEMA Administrator Peter Gaynor told Axios. “This pandemic, it is historic, it is unprecedented in many ways for FEMA.”

Nearly 30% of the crew on the USS Kidd, the second coronavirus-stricken warship, has tested positive for the virus, CNN reported on Friday. The infection rate is higher than the USS Theodore Roosevelt, which had about a 24% infection rate. 

The Election Assistance Commission confirmed states could use their grants from the CARES Act for Internet voting initiatives. Three states are planning to let some individuals vote online in upcoming primaries and caucuses (two of which added the option due to the pandemic). Some election security experts pushed back on the decision because of the security risks, Politico reported

On Friday and Saturday protesters in California and West Virginia, respectively, sought to draw attention to the Federal Bureau of Prisons’ response to the coronavirus outbreak. In San Pedro, California, prisoners’ family members rallied against the living conditions at a low-security correctional institution. In Morgantown, West Virginia, correctional officers union members called on the BOP to stop transferring inmates to the state in order to prevent further spread of the virus. 

“We have no positive cases from staff or inmates at [Federal Correctional Complex] Hazelton and our three states Maryland, Pennsylvania, and West Virginia want to keep it that way (staff live in all three). Our representatives have done an outstanding job voicing their concerns to the director and attorney general,” Justin Tarovisky, AFGE Local 420 Executive Vice President told Government Executive. “Senator [Joe] Manchin, Senator [Shelley Moore] Capito, Congressman [David] McKinley and Governor [Jim] Justice have all heard our voices, and do not want the transfer of these inmates to FCC Hazleton.”

Rep. Fred Keller, R-Pa., introduced legislation on Friday that would require the BOP director to receive Senate confirmation. “After years of out of control spending and actions that run counter to institutional safety, especially during the COVID-19 pandemic, it is abundantly clear that increased oversight of the BOP is long overdue,” said Keller. “Making the position of BOP Director Senate confirmable will ensure that the American people have a say in this important role and that the BOP will remain responsive to their representatives in Congress. The American public expects their government to be accountable to them.” Keller has been calling on the agency to suspend all inmate transfers during the pandemic. 

Former National Park Service employees outlined their desired requirements for reopening national parks. See the full list from the Coalition to Protect America’s National Parks here

Today’s GovExec Daily podcast episode looks at political influence on science performed by career civil servants and other scientists following the demotion of Dr. Rick Bright from head of the agency that is central to vaccine development.

Help us understand the situation better. Are you a federal employee, contractor or military member with information, concerns, etc. about how your agency is handling the coronavirus? Email us at newstips@govexec.com.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.